Other ulcerative colitis with fistula
ICD-10 K51.813 is a billable code used to indicate a diagnosis of other ulcerative colitis with fistula.
K51.813 refers to 'Other ulcerative colitis with fistula,' a subtype of ulcerative colitis characterized by inflammation and ulceration of the colonic mucosa, leading to the formation of abnormal connections (fistulas) between the colon and adjacent structures. Clinically, patients may present with symptoms such as abdominal pain, diarrhea (often bloody), weight loss, and fatigue. The presence of a fistula can complicate the clinical picture, potentially leading to additional symptoms such as fecal incontinence or recurrent infections. The anatomy involved primarily includes the colon, but fistulas may connect to the bladder, vagina, or skin, depending on their location. Disease progression can vary; some patients may experience intermittent flares, while others may have a more chronic course. Diagnostic considerations include colonoscopy, imaging studies (like CT or MRI), and laboratory tests to assess inflammation and rule out other conditions. Accurate diagnosis is crucial for effective management and treatment planning.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
K51.813 covers ulcerative colitis with the presence of fistulas, which may involve connections to other organs or tissues. This includes fistulas that may lead to complications such as abscess formation or recurrent infections.
K51.813 should be used when the patient has a confirmed diagnosis of ulcerative colitis accompanied by a fistula. It is important to differentiate from codes that do not specify fistula presence, as this impacts treatment and management strategies.
Documentation should include a comprehensive clinical evaluation, imaging studies confirming the fistula, treatment plans, and any relevant laboratory results. Detailed notes on the patient's symptoms and response to treatment are also essential.
